Literature DB >> 32744058

Extreme corneal flattening following collagen crosslinking for progressive keratoconus.

Prema Padmanabhan1, Michael W Belin2, Vasanthi Padmanaban1, Rachapalle Reddi Sudhir1.   

Abstract

PURPOSE: To study the clinical, tomographic and densitometric features of eyes that showed >5 D of corneal flattening following collagen crosslinking (CXL) for progressive keratoconus and to identify preoperative predictive factors for such a response.
METHODS: This was a retrospective case control study of 548 eyes with progressive keratoconus which had undergone epithelium-off CXL (Dresden protocol) with a follow-up of 1 to 10 years. Eyes that showed ⩾5 D corneal flattening in maximum keratometry (Kmax) following CXL (group A) were compared with one eye of the remaining patients in the same cohort (group B). Changes in refraction and visual acuity, Kmax and thinnest pachymetry were compared between both groups. Univariate and multivariate regression analysis identified preoperative risk factors for unusual corneal flattening.
RESULTS: Forty three eyes in group A were compared with 502 eyes in group B. At the time of maximum flattening, group A showed more flattening (-7.6 ± 3.2 D) and thinning (-53.7 ± 45.2 µ) than group B (-1.69 ± 2.9 D and -26.6 ± 36.7 µ, respectively). Multivariate analysis based on parameters suggested by a univariate regression analysis identified pre-op Kmax to be the most significant predictor of intense corneal flattening. A subgroup analysis of K-matched eyes revealed that the duration of time following CXL was a significant risk factor for extreme corneal flattening following CXL.
CONCLUSION: An intense corneal flattening >5 D in Kmax was documented in 7.85% of a cohort of keratoconus patients who underwent CXL. High preoperative Kmax and the duration of time following CXL were significant predictors of this response which was accompanied by significant corneal thinning.

Entities:  

Keywords:  Collagen crosslinking; extreme corneal flattening; keratoconus

Mesh:

Substances:

Year:  2020        PMID: 32744058     DOI: 10.1177/1120672120947664

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  2 in total

1.  Comment on: "What are the costs, capacity, and clinical implications of "waiting for documented progression" in young West of Scotland patients prior to collagen cross linking?"

Authors:  David O'Brart; Mehran Zarei-Ghanavati; Alfonso Vasquez-Perez; Christopher Liu
Journal:  Eye (Lond)       Date:  2021-08-18       Impact factor: 4.456

2.  Comparison of Long-Term Outcomes and Refractive Stability following SMILE versus SMILE Combined with Accelerated Cross-Linking (SMILE XTRA).

Authors:  Sheetal Brar; Skanda Sriganesh; Smith Snehal Sute; Sri Ganesh
Journal:  J Ophthalmol       Date:  2022-02-28       Impact factor: 1.909

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.